1. Home
  2. Labeler Index
  3. Preferred Pharmaceuticals Inc.
  4. 68788-8429
  5. Product Images: Budesonide Inhalation

Product Images Budesonide Inhalation

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Budesonide Inhalation NDC 68788-8429 by Preferred Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Budesonide Inhalation Suspension 0.25mg per 2mL - 1D139A25 9C17 4B3E 8FFD B2D562CC00EE 00

Budesonide Inhalation Suspension 0.25mg per 2mL - 1D139A25 9C17 4B3E 8FFD B2D562CC00EE 00

This text is a description of Budesonide Inhalation Suspension, a generic medicine used to treat respiratory problems such as asthma and COPD. The suspension comes in ampoules, with each individual ampoule holding 2ml of a sterile suspension containing 0.25mg of micronized budesonide. It's manufactured by Amneal Pharmaceuticals, and must be stored upright at a temperature between 20°C and 25°C. Each package comes with a lot number, batch number, and expiration date. The text includes instructions in both English and Spanish, cautioning against the transfer of the drug to anyone other than the patient it was prescribed to. The cost is presumably covered by health insurance.*

Chemical Structure Formula of Budesonide - budesonide inhalation suspension 1

Chemical Structure Formula of Budesonide - budesonide inhalation suspension 1

Figure 1: A 12-Week Trial in Pediatric Patients Previously Maintained on Inhaled Corticosteroid Therapy Prior to Study Entry. Nighttime Asthma Change from Baseline - budesonide inhalation suspension 2

Figure 1: A 12-Week Trial in Pediatric Patients Previously Maintained on Inhaled Corticosteroid Therapy Prior to Study Entry. Nighttime Asthma Change from Baseline - budesonide inhalation suspension 2

This text appears to be a chart or graph displaying the mean change from baseline nighttime asthma symptoms during a 12-week period. It includes measurements taken during different intervals, indicated by different weeks, ranging from week 0 to week 12. Placebo and two different doses of medication (0.25 mg and 0.5 mg, taken twice daily) are indicated. However, without additional context or a visual representation of the chart, it is difficult to fully interpret or provide more specific information.*

Figure 2: A 12-Week Trial in Pediatric Patients Either Maintained on Bronchodilators Alone or Inhaled Corticosteroid Therapy Prior to Study Entry. Nighttime Asthma Change from Baseline - budesonide inhalation suspension 3

Figure 2: A 12-Week Trial in Pediatric Patients Either Maintained on Bronchodilators Alone or Inhaled Corticosteroid Therapy Prior to Study Entry. Nighttime Asthma Change from Baseline - budesonide inhalation suspension 3

This is a chart representing the progress of nighttime asthma symptoms over a period of 12 weeks, categorized by the type of medication taken. The medication used is either a placebo or a 0.25mg or 0.5mg dose, taken twice daily. There are no further details available.*

Figure 1 Open the sealed foil envelope along the dotted line and take out 1 single-dose ampule from the strip. - budesonide inhalation suspension 4

Figure 1 Open the sealed foil envelope along the dotted line and take out 1 single-dose ampule from the strip. - budesonide inhalation suspension 4

Figure 2 Gently shake the budesonide inhalation suspension ampule using a circular motion - budesonide inhalation suspension 5

Figure 2 Gently shake the budesonide inhalation suspension ampule using a circular motion - budesonide inhalation suspension 5

Figure 3 Hold the budesonide inhalation suspension ampule upright without squeezing the ampule and open by twisting off the top. - budesonide inhalation suspension 6

Figure 3 Hold the budesonide inhalation suspension ampule upright without squeezing the ampule and open by twisting off the top. - budesonide inhalation suspension 6

4. Place the open end of the budesonide inhalation suspension ampule into the nebulizer cup (reservoir) and slowly squeeze all of the medicine from the ampule into the nebulizer medicine cup as shown in Figure 4. Throw away the empty ampule. - budesonide inhalation suspension 7

4. Place the open end of the budesonide inhalation suspension ampule into the nebulizer cup (reservoir) and slowly squeeze all of the medicine from the ampule into the nebulizer medicine cup as shown in Figure 4. Throw away the empty ampule. - budesonide inhalation suspension 7

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.